Characterization of olanzapine (LY170053) in human liver slices by liquid chromatography tandem mass spectrometry

Citation
At. Murphy et al., Characterization of olanzapine (LY170053) in human liver slices by liquid chromatography tandem mass spectrometry, J MASS SPEC, 33(12), 1998, pp. 1237-1245
Citations number
22
Categorie Soggetti
Chemistry & Analysis","Spectroscopy /Instrumentation/Analytical Sciences
Journal title
JOURNAL OF MASS SPECTROMETRY
ISSN journal
10765174 → ACNP
Volume
33
Issue
12
Year of publication
1998
Pages
1237 - 1245
Database
ISI
SICI code
1076-5174(199812)33:12<1237:COO(IH>2.0.ZU;2-A
Abstract
Olanzapine metabolism was investigated using incubation of olanzapine with human liver slices. The intent of the investigation was to identify olanzap ine metabolites and determine if the human liver slice incubations could po tentially produce quantities of the olanzapine glucuronides for future stud ies. Along with known Phase 1 olanzapine metabolites, N-desmethyl-, 2-hydro xymethyl-, and 4'-N-oxide-, a new hydroxylated species was detected. Detect ion of Phase 2 metabolites included known N-10-glucuronides, a quaternary g lucuronide and a novel glucuronide conjugate. This investigation showed the feasibility of using human liver slices to produce sufficient quantities o f olanzapine glucuronides for further studies. (C) 1998 John Whey & Sons, L td.